Column Capital Advisors, LLC Merck & Co., Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 8,699 shares of MRK stock, worth $831,189. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,699
Previous 4,819
80.51%
Holding current value
$831,189
Previous $556,000
60.97%
% of portfolio
0.05%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding MRK
# of Institutions
3,816Shares Held
1.86BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$23.9 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.4 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.24 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.65 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $242B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...